US Q3 Consumer Health Earnings Preview: Coming Changes Overshadow Current Conditions?
Rather than reflecting what’s coming in the way of spinoffs, leadership, product approvals or deal closings, firms’ July-September results will reveal influences from inflation and supply chain problems. Like manufacturers across industries, US consumer health product firms are dealing with US currency strengthening and potentially driving down revenues through losses in foreign exchange.
You may also be interested in...
Strongest US Cough/Cold Season In 10 Years Likely
Increasing numbers cough/cold drug prescriptions combined with consumers’ waning interest in flu vaccines point to 2022-2023 season rivaling decade-high levels from 2017-18 and to retailers boosting inventories through year-end, Raymond James analysts say.
Londoners Get J&J Brands 'In Minutes' 24/7 Via Zapp Partnership
Johnson & Johnson's OTC brands including Benadryl, Benylin, Calpol, Imodium, Nicorette and Sudafed, as well as its personal care brands such as Aveeno and Neutrogena, are now available for home delivery 24/7 via the Zapp app to consumers in London, UK.
Branding For J&J’s Kenvue Cements Consumer Division Separation
In advance of spinning off its consumer division in 2023, Johnson & Johnson has announced the new standalone company will be called Kenvue.